SynCore Biotechnology Co.,Ltd (TPEX:4192)
Taiwan
· Delayed Price · Currency is TWD 20.90
-0.30 (-1.42%)
Mar 10, 2026, 1:16 PM CST
TPEX:4192 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -46.41 | -54.28 | -38.17 | -188.67 | -458.6 | -398.92 | Upgrade
|
| Depreciation & Amortization | 17.52 | 17.85 | 19.09 | 38.86 | 17 | 20.46 | Upgrade
|
| Other Amortization | 0.22 | 0.33 | 0.57 | 1.21 | 35.43 | 36 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.3 | -0.3 | - | 0.13 | - | -0.39 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.08 | - | - | - | - | - | Upgrade
|
| Other Operating Activities | -0.09 | 0.01 | -60.41 | -0.06 | -0.06 | -1.52 | Upgrade
|
| Change in Accounts Receivable | -2.74 | 0.17 | -0.77 | 0.01 | -0.57 | -0.01 | Upgrade
|
| Change in Inventory | -1.47 | -6.93 | 14.36 | -0.3 | 0.67 | -14.99 | Upgrade
|
| Change in Accounts Payable | -0.06 | 9.32 | -0.32 | 0.32 | -11.4 | 11.29 | Upgrade
|
| Change in Other Net Operating Assets | 2.93 | -15.4 | -16.73 | -61.11 | 187.67 | 31.44 | Upgrade
|
| Operating Cash Flow | -29.84 | -49.24 | -82.37 | -209.61 | -229.86 | -316.63 | Upgrade
|
| Capital Expenditures | -0.17 | -0.21 | -0.42 | -0.14 | -0.29 | -5.12 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.01 | - | 0.39 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.17 | -0.25 | -0.35 | -0.9 | -1.35 | -0.9 | Upgrade
|
| Investment in Securities | 0.54 | - | - | - | - | - | Upgrade
|
| Other Investing Activities | -0.39 | - | -0.02 | - | - | -0.01 | Upgrade
|
| Investing Cash Flow | -0.19 | -0.46 | -0.78 | -1.03 | -1.64 | -5.64 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 140 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 30 | - | 30 | Upgrade
|
| Total Debt Issued | - | - | - | 30 | - | 170 | Upgrade
|
| Short-Term Debt Repaid | - | - | -60 | -60 | -60 | - | Upgrade
|
| Long-Term Debt Repaid | - | -9.51 | -10.61 | -43.21 | -43.19 | -13 | Upgrade
|
| Total Debt Repaid | -9.59 | -9.51 | -70.61 | -103.21 | -103.19 | -13 | Upgrade
|
| Net Debt Issued (Repaid) | -9.59 | -9.51 | -70.61 | -73.21 | -103.19 | 157 | Upgrade
|
| Issuance of Common Stock | - | - | 149.28 | - | 348.5 | 349.98 | Upgrade
|
| Other Financing Activities | - | - | - | - | - | -31.85 | Upgrade
|
| Financing Cash Flow | -9.59 | -9.51 | 78.68 | -73.21 | 245.31 | 475.13 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | 0 | 0.03 | 0.03 | -0.08 | 0.03 | Upgrade
|
| Net Cash Flow | -39.6 | -59.21 | -4.45 | -283.83 | 13.74 | 152.88 | Upgrade
|
| Free Cash Flow | -30 | -49.45 | -82.79 | -209.75 | -230.15 | -321.76 | Upgrade
|
| Free Cash Flow Margin | -114.27% | -211.89% | -409.92% | -1322.74% | -3316.73% | -2412.70% | Upgrade
|
| Free Cash Flow Per Share | -0.85 | -1.41 | -2.58 | -6.82 | -7.58 | -11.57 | Upgrade
|
| Cash Interest Paid | 0.22 | 0.3 | 0.81 | 2.31 | 2.1 | 5 | Upgrade
|
| Levered Free Cash Flow | -14.19 | -31.41 | -73.89 | -143.2 | -60.81 | -204.59 | Upgrade
|
| Unlevered Free Cash Flow | -14.05 | -31.22 | -73.4 | -141.78 | -59.54 | -202.48 | Upgrade
|
| Change in Working Capital | -0.69 | -12.85 | -3.45 | -61.08 | 176.37 | 27.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.